Evercrest Research was established in 2016 by a team of biochemists and analytical chemists who saw a persistent reliability problem in the academic peptide supply chain. Too many research programs were stalling because suppliers couldn't consistently deliver what they claimed on the label. We built Evercrest Research to fix that — starting with independent verification and working backward to every step of synthesis and quality control.
Every compound we ship is tested by a third-party ISO/IEC 17025-accredited laboratory before release. We never self-certify. The COA attached to your order comes from a lab with no financial interest in the result.
Lot-specific certificates of analysis, chain-of-custody records, and synthesis documentation are available for every batch. We don't hide behind product-line testing averages.
All Evercrest Research compounds are synthesized in ISO-certified, FDA-registered US facilities under validated cGMP protocols. We do not source from unregulated overseas manufacturers.
Our founding team brings over four decades of combined experience in peptide chemistry, analytical science, and pharmaceutical manufacturing compliance.
Dr. Kim completed her doctorate in biochemistry at UC San Diego, where her dissertation focused on solid-phase peptide synthesis optimization for research-grade therapeutic analogs. She completed post-doctoral work at Scripps Research Institute before co-founding Evercrest Research in 2016. She oversees all compound development, synthesis protocols, and third-party analytical partnerships. She has published 14 peer-reviewed studies on peptide stability, bioavailability, and synthesis methodology.
Dr. Webb spent 11 years as a senior scientist at Pfizer Global R&D, specializing in HPLC method development and mass spectrometry-based identity confirmation for pharmaceutical compounds. He joined Evercrest Research in 2017 to build and manage the company's third-party testing framework. Under his leadership, Evercrest Research has maintained a 100% lot release rate against its purity specifications across more than 3,200 batches.
Sarah holds a Master's degree in pharmaceutical sciences from the University of Southern California and is a Certified Quality Auditor (CQA). She spent 9 years managing ISO documentation and regulatory correspondence for a contract pharmaceutical manufacturer before joining Evercrest Research. She leads all GMP compliance activities, supplier qualification, and annual third-party facility audits.
Evercrest Research is headquartered in Rockville, MD. Our primary synthesis and quality control operations are co-located with our ISO-certified manufacturing partner facility.